Shane Maltbie - Jan 6, 2023 Form 3 Insider Report for HilleVax, Inc. (HLVX)

Role
Chief Financial Officer
Signature
/s/ Paul S. Bavier, Attorney-in-Fact for Shane Maltbie
Stock symbol
HLVX
Transactions as of
Jan 6, 2023
Transactions value $
$0
Form type
3
Date filed
1/10/2023, 04:00 PM
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HLVX Common Stock 899 Jan 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HLVX Stock Option (Right to Buy) Jan 6, 2023 Common Stock 92.5K $6.99 Direct F2
holding HLVX Stock Option (Right to Buy) Jan 6, 2023 Common Stock 16.8K $8.05 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the HilleVax, Inc. employee stock purchase plan on November 15, 2022.
F2 The option vested with respect to 25% of the shares of common stock on December 6, 2022 and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.
F3 The option will vest with respect to 25% of the shares of common stock on March 10, 2023 and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.

Remarks:

Exhibit 24 - Power of Attorney